As the clock ticks down on 2024, Novo Holdings’ proposed $16.5 billion buyout of CDMO giant Catalent—which the companies have ...
ViiV Healthcare wants people to go deep when talking about HIV rather than merely skimming the surface of the experience of ...
Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...
Amid ongoing speculation about how the biopharmaceutical sector will fare under Donald Trump's second presidency, the ...
Despite expanding and adding hundreds of new jobs in states like Ohio in the past year, biomanufacturing CDMO National ...
That’s according to the latest data from real-time ad trackers iSpot.TV. Their analysts found AbbVie’s immunology drug duo ...
LinkedIn likes have landed drugmakers in trouble once again. AstraZeneca—a repeat offender—and GSK were the subjects of the ...
Novo will drop its U.S. list price for its Fiasp by 75% and for Tresiba by 72%, the Danish company said in a release. The new ...
Taiwan-headquartered PharmaEssentia has tapped Joseph Horvat as its new global chief commercial officer as it looks to boost ...
Teva has reached an agreement to sell Teva Takeda Pharma to JKI, which was established by private equity firm J-Will Partners, the Israeli pharma company said Thursday. To make the deal happen, Takeda ...